19-41999226-C-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_002088.5(GRIK5):āc.2588G>Cā(p.Arg863Pro) variant causes a missense change. The variant allele was found at a frequency of 0.00000329 in 1,521,406 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000020 ( 0 hom., cov: 32)
Exomes š: 0.0000015 ( 0 hom. )
Consequence
GRIK5
NM_002088.5 missense
NM_002088.5 missense
Scores
1
2
16
Clinical Significance
Conservation
PhyloP100: 5.34
Genes affected
GRIK5 (HGNC:4583): (glutamate ionotropic receptor kainate type subunit 5) This gene encodes a protein that belongs to the glutamate-gated ionic channel family. Glutamate functions as the major excitatory neurotransmitter in the central nervous system through activation of ligand-gated ion channels and G protein-coupled membrane receptors. The protein encoded by this gene forms functional heteromeric kainate-preferring ionic channels with the subunits encoded by related gene family members. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.16642147).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GRIK5 | NM_002088.5 | c.2588G>C | p.Arg863Pro | missense_variant | 20/20 | ENST00000593562.6 | NP_002079.3 | |
GRIK5 | XM_011526862.3 | c.2591G>C | p.Arg864Pro | missense_variant | 20/20 | XP_011525164.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GRIK5 | ENST00000593562.6 | c.2588G>C | p.Arg863Pro | missense_variant | 20/20 | 5 | NM_002088.5 | ENSP00000470251 | P1 | |
GRIK5 | ENST00000262895.7 | c.2588G>C | p.Arg863Pro | missense_variant | 19/19 | 1 | ENSP00000262895 | P1 | ||
GRIK5 | ENST00000454993.6 | n.1465G>C | non_coding_transcript_exon_variant | 9/9 | 1 | |||||
GRIK5 | ENST00000602210.1 | downstream_gene_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151896Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
3
AN:
151896
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000173 AC: 2AN: 115460Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 64048
GnomAD3 exomes
AF:
AC:
2
AN:
115460
Hom.:
AF XY:
AC XY:
0
AN XY:
64048
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000146 AC: 2AN: 1369400Hom.: 0 Cov.: 33 AF XY: 0.00000148 AC XY: 1AN XY: 675650
GnomAD4 exome
AF:
AC:
2
AN:
1369400
Hom.:
Cov.:
33
AF XY:
AC XY:
1
AN XY:
675650
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152006Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74292
GnomAD4 genome
AF:
AC:
3
AN:
152006
Hom.:
Cov.:
32
AF XY:
AC XY:
2
AN XY:
74292
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 11, 2023 | The c.2588G>C (p.R863P) alteration is located in exon 19 (coding exon 19) of the GRIK5 gene. This alteration results from a G to C substitution at nucleotide position 2588, causing the arginine (R) at amino acid position 863 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
.;T
M_CAP
Uncertain
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L
MutationTaster
Benign
D
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;.
REVEL
Benign
Sift
Benign
T;.
Sift4G
Benign
T;T
Polyphen
D;D
Vest4
MutPred
Gain of glycosylation at R863 (P = 0.0019);Gain of glycosylation at R863 (P = 0.0019);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at